文献速递药物不良反应与药物警戒

基层医疗质量处方指标、规则与标准的范围综述

A scoping review of quality prescribing indicators, rules and criteria for primary care.
PubMed 文献 · Br J Clin Pharmacol · 2026-04-30

本研究通过检索四个数据库2000至2025年的文献,系统总结基层医疗中质量处方指标、规则与标准。研究凸显处方规则广泛但方法学多样性有限,需未来研究优化新兴疗法。

要点

  • 基层医疗质量处方规则覆盖54个治疗领域,共提取1486条规则。
  • 多数规则针对老年患者,仅3项研究明确适用于一般成人人群。
  • 规则最多的治疗组为精神兴奋药、精神抑制药和抗血栓药。

核心结论

  • 本综述凸显了基层医疗处方规则的广泛性、方法学多样性有限,以及未来研究优化新兴疗法的必要性。

研究设计与样本

  • 范围综述,检索OVID-MEDLINE、OVID-Embase、EBSCOhost-PsycINFO和ProQuest-International Pharmaceutical Abstracts四个数据库,纳入2000至2025年发表的文献。
  • 使用人工智能软件ASReview®辅助筛选标题和摘要,最终全文审查133篇文献,包括11篇质量处方指标综述。

主要发现

  • 多数研究聚焦老年患者,仅3项研究明确适用于一般成人人群,6项研究聚焦特定医疗状况。
  • 规则数量最多的治疗组为精神兴奋药、精神抑制药和抗血栓药。

关键数值与推荐

  • 处方规则总数1486条,覆盖54个治疗领域。
  • 仅3项研究明确规则适用于一般成人人群,6项研究聚焦特定医疗状况。

临床怎么用

  • 临床药师可参考本综述汇总的处方规则,识别高风险用药问题并监测处方行为。
  • 针对老年患者及精神兴奋药、精神抑制药、抗血栓药等规则密集领域,可优先应用质量处方指标进行处方审核。

局限性

  • 方法学多样性有限。
  • 多数规则针对老年患者,对一般成人人群的适用性证据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medication-related problems (MRPs) place a substantial burden on the healthcare system, contributing to hospital admissions and significant healthcare costs. Quality prescribing indicators (QPIs), rules and criteria serve to educate prescribers about high risk MRPs and to monitor prescribing behaviours. This study aims to summarize existing indicators, rules and criteria for quality prescribing of medicines in primary care. Four databases (OVID-MEDLINE, OVID-Embase, EBSCOhost-PsycINFO and ProQuest-International Pharmaceutical Abstracts) were searched for studies published between 2000 and 2025, across three intersecting areas: (i) general or family practice setting, (ii) prescriptions/medicines/medication/drugs and (iii) quality indicators/rules/best practice. Artificial intelligence software ASReview® assisted by prioritizing titles and abstracts for screening. To be included, the manuscript had to describe the development of novel rules relevant to primary care settings, be specific to medications or conditions and not address the general writing of a prescription. Of the 41 962 papers identified, 1859 were title and abstract screened by the review team before reaching our threshold of 420 consecutively irrelevant papers. Full-text review of 133 papers, including 11 reviews of QPIs, resulted in 1486 prescribing rules, covering 54 therapeutic areas, being extracted. Most studies focused on older patients, only three specified they were applicable to a general adult population and six focused on specific medical conditions. Therapeutic groups with the most rules were psychoanaleptics, psycholeptics and antithrombotic agents. This review highlights the breadth of prescribing rules, limited methodological diversity and the need for future research to optimize emerging therapies.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Nind J, Mackintosh A, Maddock E, et al. A scoping review of quality prescribing indicators, rules and criteria for primary care. Br J Clin Pharmacol. 2026. PMID: 42063282. doi:10.1002/bcp.70591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。